§FMCSR.com
Historical textIn force on Jan. 21, 2022Source: eCFR

§ 382.213 Controlled substance use.

Wording in the annual edition revised as of Oct. 1, 2012, superseded November 17, 2023.

eCFR as of January 21, 2022 ↗

(a) No driver shall report for duty or remain on duty requiring the performance of safety sensitive functions when the driver uses any drug or substance identified in 21 CFR 1308.11 Schedule I.

(b) No driver shall report for duty or remain on duty requiring the performance of safety-sensitive functions when the driver uses any non-Schedule I drug or substance that is identified in the other Schedules in 21 CFR part 1308 except when the use is pursuant to the instructions of a licensed medical practitioner, as defined in § 382.107, who is familiar with the driver's medical history and has advised the driver that the substance will not adversely affect the driver's ability to safely operate a commercial motor vehicle.

(c) No employer having actual knowledge that a driver has used a controlled substance shall permit the driver to perform or continue to perform a safety-sensitive function.

(d) An employer may require a driver to inform the employer of any therapeutic drug use.

[77 FR 4483, Jan. 30, 2012]

Amendment history

4 distinct wordings on file since Oct. 1, 1996
  1. [77 FR 4483, Jan. 30, 2012, as amended at 88 FR 80180, Nov. 17, 2023]
  2. Oct. 1, 2012 → Nov. 17, 2023annual editions 2012–2016diff vs. previousviewing
    [77 FR 4483, Jan. 30, 2012]
  3. Oct. 1, 1996 → Oct. 1, 2001annual editions 1996–2000

A new entry appears whenever the regulatory words change between government snapshots. Day-precise from the eCFR (2017 onward); before that, one snapshot per annual CFR edition (revised as of October 1). Bracketed citations are the Federal Register history printed with the section.